Reneo Pharmaceuticals Inc (RPHM)
1.72
+0.06
(+3.61%)
USD |
NASDAQ |
May 17, 16:00
1.70
-0.02
(-1.16%)
After-Hours: 20:00
Reneo Pharmaceuticals Cash from Financing (Quarterly): 0.00 for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.00 |
| December 31, 2023 | -4.128M |
| September 30, 2023 | 0.173M |
| June 30, 2023 | 63.81M |
| March 31, 2023 | 1.009M |
| December 31, 2022 | 0.325M |
| September 30, 2022 | 0.097M |
| June 30, 2022 | 0.043M |
| March 31, 2022 | 0.006M |
| Date | Value |
|---|---|
| December 31, 2021 | 0.119M |
| September 30, 2021 | 0.222M |
| June 30, 2021 | 85.84M |
| March 31, 2021 | 46.22M |
| December 31, 2020 | 47.20M |
| September 30, 2020 | 0.051M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.026M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-4.128M
Minimum
Dec 2023
85.84M
Maximum
Jun 2021
14.18M
Average
0.119M
Median
Dec 2021
Cash from Financing (Quarterly) Benchmarks
| Mirum Pharmaceuticals Inc | 1.205M |
| NovaBay Pharmaceuticals Inc | -0.597M |
| Palatin Technologies Inc | 9.136M |
| iBio Inc | 4.005M |
| Theriva Biologics Inc | 0.00 |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -21.01M |
| Cash from Investing (Quarterly) | 13.76M |
| Free Cash Flow | -75.65M |
| Free Cash Flow Per Share (Quarterly) | -0.6288 |
| Free Cash Flow Yield | -132.0% |